Growth in the Number of Ozempic Lawsuits Since the initial lawsuits were filed, the number of cases related to Ozempic has grown significantly from less than 100 to over 1,200 as of November 2024
[7] Pre-clinical research has indicated that BPC-157 may have cytoprotective, neuroprotective, and anti-inflammatory effects, and may also accelerate tissue and organ healing
Stopping at the first sign of fullness is one of the best ways to avoid nausea
2 Adverse side effects of Tirzepatide are diverse, including acute pancreatitis, cholelithiasis, severe hypoglycemia, and cholecystitis which have been reported to be present in less than 1% of all doses of Tirzepatide, along with anaphylaxis in some patients
This underscores a CDMO strategy: leveraging a broad manufacturing network (mammalian, bacterial, sterile filling) to serve glp-1 and other high-growth biologics